US2017096635A1PendingUtilityA1
Lactic bacterium for texturizing food products selected on the basis of phage resistance
Est. expiryJan 28, 2030(~3.5 yrs left)· nominal 20-yr term from priority
C12Y 207/01006C12N 1/20C12N 9/1205A23Y 2240/75A23Y 2220/15A23C 9/1238A23C 9/1209A23C 9/123C12N 1/06A23C 9/12C12R 2001/225C12R 2001/46C12N 1/205A23C 2220/202C12N 15/01C12Q 1/14C12N 15/746A23V 2400/143A23V 2400/11A23V 2400/123A23V 2400/249
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products fermented with the starter culture.
Claims
exact text as granted — not AI-modified1 .- 48 . (canceled)
49 . A method for manufacturing a lactic acid bacterium (LAB) having a mutation in the −10 region of a galactokinase (GalK) gene, comprising:
producing, from a mother LAB strain, a mutant LAB strain having a mutation in the −10 region of the GalK gene, and then
selecting the mutant LAB strain,
wherein the mutant LAB strain (i) exhibits enhanced galactose-degrading activity during milk fermentation as compared the mother LAB strain and (ii) produces milk that has a higher viscosity than milk produced with the mother LAB strain under comparable conditions.
50 . The method of claim 49 , wherein the mother LAB strain has a GalK gene with the nucleotide sequence TACGAT (SEQ ID NO: 7) in the −10 region.
51 . The method of claim 50 , wherein the method results in the replacement of one or both of C and G in the TACGAT sequence of the mother LAB strain with a nucleotide independently selected from A and T.
52 . The method of claim 49 , wherein the mutant LAB strain has a GalK gene with a nucleotide sequence selected from TATGAT (SEQ ID NO:8), TATTAT (SEQ ID NO:9), and TACTAT (SEQ ID NO:10) in the −10 region.
53 . The method of claim 49 , wherein the mutant LAB strain is a Streptococcus thermophilus strain.
54 . The method of claim 49 , wherein the mutant LAB strain is produced by a method comprising one or more of genetic engineering, radiation treatment, and chemical treatment.
55 . A LAB which is obtained by the method of claim 49 .
56 . A mutated lactic acid bacterium (LAB) having a galactokinase (GalK) gene with a nucleotide sequence selected from TATGAT (SEQ ID NO:8), TATTAT (SEQ ID NO:9), and TACTAT (SEQ ID NO:10) in the −10 region.
57 . The mutated LAB of claim 56 , wherein the LAB is a Streptococcus thermophilus bacterium.
58 . The mutated LAB of claim 57 , wherein the Streptococcus thermophilus bacterium is selected from CHCC11379 (DSM 22884), CHCC11342 (DSM 22932), CHCC11976 (DSM22934), and functionally equivalent mutants of any of these.
59 . A composition comprising the LAB of claim 56 .
60 . The composition of claim 59 , wherein the composition further comprises one or more additional LAB strains selected from Lactobacillus bulgaricus strains, Lactobacillus johnsonii strains, and Lactobacillus fermentum strains.
61 . The composition of claim 60 , wherein the additional LAB strain produces a polysaccharide and/or a fructosyl transferase enzyme.
62 . The composition of claim 60 , wherein the composition comprises at least 10 10 cell forming units (CFU) of the additional LAB strain and at least 10 10 CFU of the mutated LAB.
63 . A dairy product produced by a method comprising:
adding the mutated LAB strain of claim 56 to a milk substrate, and then fermenting the milk substrate.
64 . A dairy product comprising the mutated LAB of claim 56 .
65 . The dairy product of claim 64 , wherein the dairy product is selected from yoghurt, milk, and cheese.
66 . The dairy product of claim 64 , wherein the dairy product is selected from a stirred-type product, a set-type product, and a drinkable product.
67 . The dairy product of claim 64 , wherein the dairy product further comprises one or more ingredients selected from a fruit concentrate, a syrup, a probiotic bacterial culture, a coloring agent, a thickening agent, a flavoring agent, and a preserving agent.
68 . The dairy product of claim 64 , wherein the dairy product has a viscosity of more than 100 Pa, measured as shear stress at 300 s −1 .
69 . A dairy product produced by a method that comprises:
fermenting a milk or dairy substrate with (i) a Streptococcus thermophilus bacterium comprising a galactokinase (GalK) gene having a −10 region having a nucleotide sequence selected from the group consisting of TATGAT (SEQ ID NO:8), TATTAT (SEQ ID NO:9) and TACTAT (SEQ ID NO:10) and (ii) a Lactobacillus delbrueckii ssp. bulgaricus bacterium.Join the waitlist — get patent alerts
Track US2017096635A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.